Orchestra BioMed Holdings, Inc.OBIONASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+38.4%
5Y CAGR+34.0%
Year-over-Year Change
Research and development spending
3Y CAGR
+38.4%/yr
Annual compound
5Y CAGR
+34.0%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
4.3x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $58.19M | +35.9% |
| 2024 | $42.80M | +26.6% |
| 2023 | $33.82M | +54.1% |
| 2022 | $21.95M | +70.2% |
| 2021 | $12.89M | -4.4% |
| 2020 | $13.48M | - |